Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Nucleic Acids Research|October 17, 2017
Arrayed mutant haploid embryonic stem cell libraries facilitate phenotype-driven genetic screensGuang Liu, Xue Wang, Yufang Liu, et al.
Thoracic Cancer|May 6, 2016
MEK inhibitor can reverse the resistance to bevacizumab in A549 cells harboring Kirsten rat sarcoma oncogene homolog mutationYuan Wang, Ping Yan, Zhentao Liu, et al.
Cell Chemical Biology|March 31, 2016
Natural Product Kongensin A is a Non-Canonical HSP90 Inhibitor that Blocks RIP3-dependent NecroptosisDianrong Li, Chao Li, Lin Li, et al.
Oncotarget|December 15, 2015
EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatmentHongjuan Zhang, Cheng Zhan, Ji Ke, et al.
Oncotarget|November 17, 2018
Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatmentHongjuan Zhang, Cheng Zhan, Ji Ke, et al.
Frontiers in Cell and Developmental Biology|June 17, 2022
Evaluation of the EdgeSeq Precision Immuno-Oncology Panel for Gene Expression Profiling From Clinical Formalin-Fixed Paraffin-Embedded Tumor SpecimensYang Shi, Xiaopeng Ma, Wei Shen, et al.
Leukemia & Lymphoma|May 22, 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2Yang Liu, Xiaopeng Ma, Xikun Wu, et al.
Future Oncology (London, England)|June 30, 2021
High PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor in urothelial carcinomaQiaofeng Zhong, Jianzhong Shou, Jianming Ying, et al.
Molecular Cell|March 18, 2017
Pacer Mediates the Function of Class III PI3K and HOPS Complexes in Autophagosome Maturation by Engaging Stx17Xiawei Cheng, Xiuling Ma, Xianming Ding, et al.
Structure (London, England : 1993)|March 9, 2024
Structural insights into the unique pH-responsive characteristics of the anti-TIGIT therapeutic antibody OciperlimabJian Sun, Xiangxiang Zhang, Liu Xue, et al.
Pageof 4